Ciprofloxacin Dosage and Emergence of Resistance in Human Commensal Bacteria
Open Access
- 1 August 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 200 (3) , 390-398
Abstract
Background. Although optimization of the fluoroquinolone dosage increases the efficacy of this class of drugs against bacterial infections, its impactKeywords
This publication has 32 references indexed in Scilit:
- Optimizing Drug Exposure to Minimize Selection of Antibiotic ResistanceClinical Infectious Diseases, 2007
- Antimicrobial Resistance: Pharmacokinetics‐Pharmacodynamics of Antimicrobial Therapy: It’s Not Just for Mice AnymoreClinical Infectious Diseases, 2007
- Relationship between Fluoroquinolone Area under the Curve:Minimum Inhibitory Concentration Ratio and the Probability of Eradication of the Infecting Pathogen, in Patients with Nosocomial PneumoniaThe Journal of Infectious Diseases, 2004
- Emergence of Resistance in Normal Human Aerobic Commensal Flora during Telithromycin and Amoxicillin-Clavulanic Acid TreatmentsAntimicrobial Agents and Chemotherapy, 2003
- Target Site Concentrations of Ciprofloxacin after Single Intravenous and Oral DosesAntimicrobial Agents and Chemotherapy, 2002
- Population Pharmacokinetics and Use of Monte Carlo Simulation To Evaluate Currently Recommended Dosing Regimens of Ciprofloxacin in Adult Patients with Cystic FibrosisAntimicrobial Agents and Chemotherapy, 2001
- Effect of antimicrobial agents on the ecological balance of human microfloraThe Lancet Infectious Diseases, 2001
- Emerging Mechanisms of Fluoroquinolone ResistanceEmerging Infectious Diseases, 2001
- Levels of Rifampin and Ciproftoxacin in Nasal Secretions: Correlation with MIC90 and Eradication of Nasopharyngeal Carriage of BacteriaThe Journal of Infectious Diseases, 1990
- Faecal excretion of ciprofloxacin after a single oral dose and its effect on faecal bacteria in healthy volunteersJournal of Antimicrobial Chemotherapy, 1990